Copper chaperons as novel targets for therapy in triple-negative breast cancer (TNBC)

被引：0
|
作者：
Karginova, O.
Song, A.
Wang, J.
Luo, C.
Jiang, H.
He, C.
Olopade, O. I.
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA
[3] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-04-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-04-09
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Cho, Eun Yoon
    Chang, Myung Hee
    Choi, Yoon La
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 753 - 761
  • [32] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Eun Yoon Cho
    Myung Hee Chang
    Yoon La Choi
    Jeong Eon Lee
    Seok Jin Nam
    Jung-Hyun Yang
    Yeon Hee Park
    Jin Seok Ahn
    Young-Hyuck Im
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 753 - 761
  • [33] Characterization of a novel lipase inhibitor targeting high cancer stemness in triple-negative breast cancer (TNBC)
    Grundmann, Hannah
    Bozzetti, Theresa
    On, Jasmin
    Kulik, Andrea
    Niederacher, Dieter
    Neubauer, Hans
    Fehm, Tanja
    Esser, Knud
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 257 - 257
  • [34] Metabolic Imaging as a Tool to Characterize Chemoresistance and Guide Therapy in Triple-Negative Breast Cancer (TNBC)
    Sunassee, Enakshi D.
    Jardim-Perassi, Bruna Victorasso
    Madonna, Megan C.
    Ordway, Bryce
    Ramanujam, Nirmala
    MOLECULAR CANCER RESEARCH, 2023, 21 (10) : 995 - 1009
  • [35] Inducing cell state transitions in triple-negative breast cancer (TNBC).
    Loo, Ser Yue
    Toh, Liping
    Pathak, Elina
    Tan, Wilson
    Ma, Siming
    Yuan, Ju
    Periyasamy, Giridharan
    Torta, Federico
    Chan, Jack
    Tan, Tira
    Sim, Yi Rong
    Tan, Veronique
    Tan, Benita
    Madhukumar, Preetha
    Yong, Wei Sean
    Ong, Kong Wee
    Wong, Chow Yin
    Wenk, Markus R.
    Foo, Roger
    Yap, Yoon-Sim
    Lim, Elaine
    Tam, Wai Leong
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 73 - 73
  • [36] Therapeutic targets of triple-negative breast cancer: a review
    Jamdade, Vinayak S.
    Sethi, Nikunj
    Mundhe, Nitin A.
    Kumar, Parveen
    Lahkar, Mangala
    Sinha, Neeraj
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (17) : 4228 - 4237
  • [37] Identification of microRNA targets in triple-negative breast cancer
    Gill, Mandeep
    Sugita, Bruna
    Pereira, Silma R.
    Marian, Catalin
    Li, Xi
    Gusev, Yuriy
    Ribeiro, Enilze M. S. F.
    Cavalli, Iglenir J.
    Cavalli, Luciane R.
    CANCER RESEARCH, 2014, 74 (19)
  • [38] Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC).
    Steenbruggen, Tessa Gerjanne
    Van Ramshorst, Mette S.
    van Werkhoven, Erik
    Dezentje, Vincent O.
    Siesling, Sabine
    Linn, Sabine C.
    Sonke, Gabe S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer
    Skor, Maxwell N.
    Wonder, Erin L.
    Kocherginsky, Masha
    Goyal, Anju
    Hall, Ben A.
    Cai, Yi
    Conzen, Suzanne D.
    CLINICAL CANCER RESEARCH, 2013, 19 (22) : 6163 - 6172
  • [40] Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer
    Ludwik, Katarzyna A.
    Campbell, J. Preston
    Li, Mingzong
    Li, Yu
    Sandusky, Zachary M.
    Pasic, Lejla
    Sowder, Miranda E.
    Brenin, David R.
    Pietenpol, Jennifer A.
    O'Doherty, George A.
    Lannigan, Deborah A.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) : 2598 - 2608
12345